ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯¹æ¾Ï¹×¿©¼º¾ÏŬ¸®´Ð
-
[SCI]
C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition,
Tae-Min Cho, Ji Young Kima, Yoon-Jae Kim, Daeil Sung, Eunhye Oh, Seojin, Jang, Lee Farrand, Van-Hai Hoang, Cong-Truong Nguyen, Jihyae Ann, Jeewoo Lee, and Jae Hong Seo,
/ C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition,
/ 447:141-153, 2019 (IF 6.491)
/ 201907
-
[SCI]
Investigation of B, C-ring truncated deguelin derivatives as heat shock protein 90(HSP90) inhibitor for use as anti-breast cancer agents
Kim HS, Hoang VH, Hong M, Kim KC, Ann J, Nguyen CT, Seo JH, Choi H, Kim JY, Kim KW, Byun WS, Lee S, Lee S, Suh YG, Chen J, Park HJ, Cho TM, Kim JY, Seo JH, Lee J
/ Investigation of B, C-ring truncated deguelin derivatives as heat shock protein 90(HSP90) inhibitor for use as anti-breast cancer agents
/ 27(7):1370-1381, 2019 (IF 2.93) r
/ 201907
-
[SCI]
Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.
Yoon-Jae Kim, Daeil Sung, Eunhye Oh, Youngkwan Cho, Tae-Min Cho, Lee Farrand, Ji Young Kim, Jae Hong Seo,
/ Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.
/ 412:118-130, 2018
/ 201807
-
[SCI]
Current strategies of endocrine therapy in elderly patients with breast cancer.
Suk-young Lee, Jae Hong Seo,
/ Current strategies of endocrine therapy in elderly patients with breast cancer.
/ Vol 2018:1-12, 2018
/ 201807
-
[SCI]
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
Eunhye Oh, Yoon-Jae Kim, Hyunsook An, Daeil Sung, Tae-Min Cho, Lee Farrand, Seojin Jang, Jae Hong Seo, Ji Young Kim,
/ Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
/ 143(8): 1978-1993, 2018 (IF 7.36)
/ 201807